IceCure Medical Ltd (ICCM)
NASDAQ: ICCM · Real-Time Price · USD
1.030
-0.030 (-2.83%)
Sep 5, 2025, 4:00 PM - Market closed
IceCure Medical Employees
As of December 31, 2024, IceCure Medical had 66 total employees, including 64 full-time and 2 part-time employees. The number of employees decreased by 11 or -14.29% compared to the previous year.
Employees
66
Change (1Y)
-11
Growth (1Y)
-14.29%
Revenue / Employee
$42,227
Profits / Employee
-$236,061
Market Cap
81.01M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 66 | -11 | -14.29% |
| Dec 31, 2023 | 77 | 5 | 6.94% |
| Dec 31, 2022 | 72 | 8 | 12.50% |
| Dec 31, 2021 | 64 | 17 | 36.17% |
| Dec 31, 2020 | 47 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ICCM News
- 3 days ago - IceCure's ProSense® Substantially Reduces Abdominal Wall Endometriosis Pain with High Procedural Efficacy - PRNewsWire
- 25 days ago - IceCure Medical Ltd (ICCM) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 25 days ago - IceCure Reports Financial & Operational Results for the First Half of 2025 - PRNewsWire
- 4 weeks ago - IceCure to Report First Half 2025 Financial and Operating Results on August 13, 2025 - PRNewsWire
- 5 weeks ago - IceCure Announces Expiration and Results of Approximately Two Times Over-Subscribed Rights Offering for Aggregate Gross Proceeds of $10.0 Million - PRNewsWire
- 6 weeks ago - IceCure's ProSense® Featured at Japanese Breast Cancer Society Conference: Updated Positive Clinical Data Shows 99% Recurrence Free Rate with Cryoablation - PRNewsWire
- 6 weeks ago - IceCure Reminds Shareholders of Upcoming Expiration of Rights Offering Subscription Period - PRNewsWire
- 2 months ago - IceCure Announces Commencement of Rights Offering - PRNewsWire